Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...

Uncover the groundbreaking contributions of these famous scientists. Discover how their innovative discoveries and inventions profoundly shape our world today ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has released a list of 101 products whose ...

The shares of GlaxoSmithKline ($GSK) cheered on Monday after the British pharmaceutical giant announced that its chief ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

GlaxoSmithKline Pharmaceuticals shares were trading lower in Friday's session, with the stock down 2.48% to Rs 2,670.40.

Cerebras Systems’ Wafer Scale Engine 3 is described as the largest AI processor, 56 times bigger than leading GPUs.

Dame Emma Walmsley will step down as GSK’s chief executive at the end of the year, concluding nine years at the helm of Britain’s second-largest pharmaceuticals company.

Cerebras Systems' dinner plate-size chip technology has been a curiosity since the company introduced the Wafer Scale Engine ...